Bal Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 83.70 | 87.84 | 74.88 |
| Operating Expense | 73.29 | 77.82 | 67.98 |
| Net Profit | 3.70 | 1.95 | 0.78 |
| Net Profit Margin | 4.42% | 2.22% | 1.04% |
| Earning Per Share | 2.60 | 1.22 | 0.49 |
| EBIDTA | 10.79 | 10.03 | 6.91 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Mar 2026
Revenue83.70
Operating Expense73.29
Net Profit3.70
Net Profit Margin4.42
Earning Per Share2.60
EBIDTA10.79
Effective Tax Rate0
